Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 25, 2023

SELL
$146.03 - $184.54 $37,821 - $47,795
-259 Reduced 6.97%
3,459 $638,000
Q4 2022

Jan 26, 2023

SELL
$110.88 - $150.36 $324,989 - $440,705
-2,931 Reduced 44.08%
3,718 $0
Q3 2022

Oct 25, 2022

BUY
$125.58 - $169.38 $172,923 - $233,236
1,377 Added 26.12%
6,649 $938,000
Q2 2022

Jul 26, 2022

SELL
$112.97 - $151.71 $295,868 - $397,328
-2,619 Reduced 33.19%
5,272 $689,000
Q1 2022

Apr 26, 2022

SELL
$135.71 - $284.87 $51,434 - $107,965
-379 Reduced 4.58%
7,891 $1.15 Million
Q4 2021

Jan 27, 2022

SELL
$266.41 - $303.29 $152,652 - $173,785
-573 Reduced 6.48%
8,270 $2.42 Million
Q3 2021

Oct 26, 2021

SELL
$249.0 - $285.24 $99,351 - $113,810
-399 Reduced 4.32%
8,843 $2.39 Million
Q2 2021

Jul 26, 2021

BUY
$208.49 - $248.2 $115,503 - $137,502
554 Added 6.38%
9,242 $2.24 Million
Q1 2021

Apr 22, 2021

SELL
$220.31 - $283.75 $5,728 - $7,377
-26 Reduced 0.3%
8,688 $2 Million
Q4 2020

Jan 28, 2021

SELL
$223.82 - $271.35 $152,197 - $184,518
-680 Reduced 7.24%
8,714 $2.34 Million
Q3 2020

Oct 28, 2020

SELL
$209.49 - $246.81 $76,463 - $90,085
-365 Reduced 3.74%
9,394 $2.22 Million
Q2 2020

Jul 23, 2020

SELL
$178.49 - $250.39 $33,199 - $46,572
-186 Reduced 1.87%
9,759 $2.23 Million
Q1 2020

Apr 23, 2020

SELL
$148.38 - $186.78 $35,017 - $44,080
-236 Reduced 2.32%
9,945 $1.76 Million
Q4 2019

Jan 30, 2020

SELL
$140.81 - $159.49 $60,829 - $68,899
-432 Reduced 4.07%
10,181 $1.61 Million
Q3 2019

Oct 24, 2019

BUY
$145.61 - $159.87 $1.55 Million - $1.7 Million
10,613 New
10,613 $1.58 Million

Others Institutions Holding MASI

About MASIMO CORP


  • Ticker MASI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 52,530,200
  • Market Cap $8.98B
  • Description
  • Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximet...
More about MASI
Track This Portfolio

Track First Merchants Corp Portfolio

Follow First Merchants Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Merchants Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Merchants Corp with notifications on news.